JPRN-jRCTs031180369招募中1 期
Exploratory study of tolvaptan use for nephrogenic diabetes insipidus caused by mutation in vasopressin type 2 receptor - Tolvaptan use for NDI by V2R mutation
Makita Noriko0 个研究点目标入组 3 人开始时间: 2019年3月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) > 20 y.o. or 20 y.o.
- •2) nephrogenic diabetes insipidus caused by mutations in AVPR2
- •3) Principal or sub investigators judge
- •4) Written informed consent
排除标准
- •1) Allergic reactions against tolvaptan
- •2) Pregnant, unwilling to practice contraception during the study, or lactating female
- •3) < eGFR 30 mL/min/1.73m2
- •4) AST > 99 IU/L or ALT > 99 IU/L
- •5) congestive heart failure
- •6) active tuberculosis
- •7) alcohol abuse or drug abuse
- •8) participate in other studies with drug use within 4 months (if patch test, within 1 month)
- •9) blood sampling or donation 200 mL within 2 weeks, 400 mL within 12 weeks, or component blood sampling or donation within 12 weeks
- •10) Principal or sub investigators judge
研究者
相似试验
招募中
不适用
Study of the renal protective effect of tolvaptan as a replacement of loop diuretics for the treatment of ascites in cirrhotic patients with renal dysfunctioliver cirrhosisJPRN-UMIN000044693Tohoku Medical and Pharmaceutical University15
进行中（未招募）
1 期
The effects of tolvaptan on renal handeling of water and salt, hormones in the blood and the circulation, during blocking of the nitric oxide (NO) system in healthy subjects. A dose-response study.HyponatremiaSIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion)MedDRA version: 14.1Level: LLTClassification code 10021038Term: HyponatremiaSystem Organ Class: 100000004861MedDRA version: 14.1Level: LLTClassification code 10040626Term: SIADHSystem Organ Class: 100000004860EUCTR2013-003800-38-DKDepartment of Medical Research22
已完成
不适用
Renal protective effect of Samsca in patients with new-onset acute heart failureAcute heart failureJPRN-UMIN000036417Kansai Medical University Medical Center122
招募中
不适用
Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventionalJPRN-UMIN000008712Division of Kidney and Hypertension, the Jikei University School of Medicine40
已完成
不适用
The effect of tolvaptan on renal function during intensive treatment in patients with congestive heart failurecongestive heart failureJPRN-UMIN000014134ishiarai Heart Center Hospital80